国际皮肤性病学杂志    2006 32 (1): 29-31   ISSN: 2096-5540  CN: 32-1880/R   CLA+T细胞与银屑病的研究进展 韩凤娴, 徐丽敏 天津市长征医院皮肤科, 300021 收稿日期 2005-05-19  修回日期 null  网络版发布日期 null 参考文献  [1] Nakayama F,Teraki Y,Kudo T,et al.Expression of cutaneous lymphocyte-associated antigen regulated by a set of glycosyltransferases in human T cells:involvement of alpha1,3-fucosyltransferase VII and beta 1,4-galactosyltransferase I.J Invest Dermatol,2000,115:299. [2] Mizukawa Y,Shitara K,Yamazaki Y,et al.Immunohistochemical detection of skin-homing T cells expressing fucosyltransferase VII(Fuc-TVII) in vitro and in situ.Lab Invest,2001,81:771-773. [3] MizukawaY,Shitara K,Yamazaki Y,et al.Development and characterization of a monoclonal antibody specific for fucosyltransferase VII (Fuc-TVII):discordant expression of CLA and Fuc-TVII in peripheral CD4+ and CD8+ T cells.J Invest Dermatol,2001,117:743-747. [4] Hunger RE,Yawalkar N,Braathen LR,et al.The HECA-452 epitope is highly expressed on lymph cells derived from human skin.Br J Dermatol,1999,141:565-569. [5] Campbell JJ,Brightling CE,Symon FA,et al.Expression of chemokine receptors by lung T cells from normal and asthmatic subjects.J Immunol,2001,166:2842-2848. [6] Jones SM,Dixey J,Hall ND,et al.Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis.Br J Rheumatol,1997,36:748-757. [7] Teraki Y,Miyake A,Takebayashi R,et al.In vivo evidence for close association of CLA expression and E-selectin binding by T cells in the inflamed skin.J Dermatol Sci,2004,36:63-65. [8] Sigmundsdottir H,Gudjonsson JE,Jonsdottir I,et al.The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease.Clin Exp Immunol,2001,126:365-369. [9] Teraki Y,Miyake A,Takebayashi R,et al.Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris.Clin Exp Dermatol,2004,29:658-663. [10] Rottman JB,Smith TL,Ganley KG,et al.Potential role of the chemokine receptors CXCR3,CCR4,and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris.Lab Invest,2001,81:335. [11] Hudak S,Hagen M,Liu Y,et al.Immune surveillance and effector functions of CCR10(+) skin homing T cells.J Immunol,2002,169:1189-1196. [12] Homey B,Alenius H,Muller A,et al.CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.Nat Med,2002,8:157-165. [13] Homey B,Dieu-Nosjean MC,Wiesenborn A,et al.Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.J Immunol,2000,164:6621. [14] Ellis CN,Krueger GG.Alefacept Clinical Study Group.Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.N Engl J Med,2001,345:248-255. [15] Sigmundsdottir H,Johnston A,Gudjonsson JE,et al.Methotrexate markedly reduces the expression of vascular E-selectin,cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.Exp Dermatol,2004,13:426-434. [16] Schon MP,Krahn T,Schon M,et al.Efomycine M,a new specific inhibitor of selectin,impairs leukocyte adhesion and alleviates cutaneous inflammation.Nat Med,2002,8:366-372. [17] Gottlieb A,Krueger JG,Bright R,et al.Effects of administration of a single dose of a humanized monoclonal antibody to CD1 1a on the immunobiology and clinical activity of psoriasis.J Am Acad Dermatol,2000,42:428-435. [18] Lebwohl M,Tyring SK,Hamilton TK,et al.A novel targeted T-cell modulator,efalizumab,for plaque psoriasis.N Engl J Med,2003,349:2004-2013. [19] Leonardi CL,Powers JL,Matheson RT,et al.Etanercept as monotherapy in patients with psoriasis.N Engl J Med,2003,349:2014-2022. [20] Dimitroff C J,Bernaeki R J,Sackstein R.Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression:implications in modulating lymphocyte migration to skin.Blood,2003,101:602-610. 通讯作者: